BJS Academy>Continuing surgical ...>BASIL 2 results expl...
Surgical digest
BASIL-2 results explained
Andrew Bradbury
Sampson Gamgee Professor of Vascular Surgery University of Birmingham Chief Investigator of the UK NIHR HTA-funded BASIL-2 and BASIL-3 trials United Kingdom
Related articles

A contemporary overview of the management of acute ilio-femoral deep vein thrombosis; why, how and where next?
Sandip Nandhra, Emma Wilton, Steve Black
DOI: 10.58974/bjss/azbc040 Download PDF Unprovoked acute deep vein thrombosis (DVT) is a common problem, affecting around 50 to 100 per 10000 people.1,2 A significant number of these (20%) will involve the iliac veins or inferior vena cava. The symptoms of acute DVT are well described and include, sudden onset of swelling, pain, redness and difficultly mobilising. On occasion the extent of venous congestion can be so severe it threatens the limb, a phenomenon termed phlegmasia.

Chronic limb-threatening ischaemia: current knowledge and future perspectives
Fabio Stocco, Jing Yi Kwan, Marc A. Bailey, Patrick A. Coughlin
The incidence of peripheral arterial disease (PAD) has risen dramatically, and it is estimated to affect around 200 million people worldwide. This rise can be explained by an ageing population, persisting high rates of tobacco smoking and the increasing incidence of diabetes mellitus (DM).1,2 Chronic limb-threatening ischaemia (CLTI) is the most severe manifestation of PAD and is characterized by rest pain and/or tissue loss (e.g. ulceration or gangrene).1 It is estimated that CLTI affects about 10% of all patients with PAD.3 Figure 1. Typical critical ischaemia of the left foot. Patients with CLTI are at high risk of major limb amputation (MLA) and major adverse cardiovascular events (MACE – myocardial infarction and stroke)1 with a significant reduction in life expectancy. Overall mortality rates are similar to that of advanced cancers.3 They also commonly experience poor quality of life.

Widening participation in cardiothoracic healthcare: INSINC Insight
Kirstie Kirkley, Georgia R. Layton, Javeria Tariq, Heen Shamaz, Mostin Hu, Alana Atkinson, Deborah Harrington, Elizabeth Belcher, Jason Ali, Narain Moorjani, Farah Bhatti, Karen Booth
Equality, diversity and inclusion (EDI) within surgery is important.1 The recent Kennedy Review on Diversity and Inclusion, commissioned by the Royal College of Surgeons of England, made 16 recommendations to improve EDI in the surgical workforce.2 Cardiothoracic surgery in the UK lacks diversity, exemplified with only 13% of the consultant workforce being female, despite females accounting for 49% of UK doctors.3 One method of improving EDI in the specialty, is to focus on widening participation (WP) activities.
In the UK, WP activities and government policies aim to increase representation of lower socio-economic groups in higher education. Published schemes focus on peer-to-peer mentorship from medical to school students. The King’s College London scheme is a monthly seminar series offered to WP school students, publishing a 50% success rate of translation to successful application to medical school.4
Copied!
Connect

Copyright © 2026 River Valley Technologies Limited. All rights reserved.


.png)





.jpg)



